Hepion Pharmaceuticals Inc (HEPA) stock is lower by -70.49% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives HEPA stock a score of 28 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 4. HEPA's rank also includes a short-term technical score of 6.
Is Hepion Pharmaceuticals Inc (HEPA) Stock Worth a Buy Thursday?
HEPA has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on HEPA!